ETFMG Treatments Testing and Advancements ETF’s (GERM) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting ETFMG Treatments Testing and Advancements ETF is a Buy.
ETFMG Treatments Testing and Advancements ETF’s (GERM) 20-Day exponential moving average is 19.15, making it a Buy.
ETFMG Treatments Testing and Advancements ETF’s (GERM) 50-Day exponential moving average is 19.07, making it a Buy.